Keiji Nogami

5.4k total citations · 2 hit papers
283 papers, 3.6k citations indexed

About

Keiji Nogami is a scholar working on Hematology, Genetics and Surgery. According to data from OpenAlex, Keiji Nogami has authored 283 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 238 papers in Hematology, 78 papers in Genetics and 25 papers in Surgery. Recurrent topics in Keiji Nogami's work include Hemophilia Treatment and Research (205 papers), Blood Coagulation and Thrombosis Mechanisms (146 papers) and Platelet Disorders and Treatments (100 papers). Keiji Nogami is often cited by papers focused on Hemophilia Treatment and Research (205 papers), Blood Coagulation and Thrombosis Mechanisms (146 papers) and Platelet Disorders and Treatments (100 papers). Keiji Nogami collaborates with scholars based in Japan, United States and United Kingdom. Keiji Nogami's co-authors include Midori Shima, Tomoko Matsumoto, Kenichi Ogiwara, Masashi Taki, Koichiro Yoneyama, Tetsuhiro Soeda, Takehisa Kitazawa, Koji Yada, Katsuyuki Fukutake and Akira Yoshioka and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Keiji Nogami

247 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Factor VIII–Mimetic Function of Humanized Bispecific Antibody in Hemophilia A

2016 326 citations Midori Shima, Keiji Nogami et al. profile →
Efanesoctocog Alfa Prophylaxis for Patients with Severe Hemophilia A

2023 100 citations Keiji Nogami et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Keiji Nogami Japan	31	3.0k	966	325	268	252	283	3.6k
Alison M. Friedmann United States	21	210 0.1×	172 0.2×	101 0.3×	520 1.9×	224 0.9×	56	1.3k
Peter Falk Sweden	31	266 0.1×	127 0.1×	323 1.0×	520 1.9×	1.0k 4.2×	114	4.1k
G Gandini Italy	29	222 0.1×	103 0.1×	144 0.4×	1.3k 4.7×	967 3.8×	164	3.7k
W. Paul Bowman United States	29	2.5k 0.8×	482 0.5×	678 2.1×	221 0.8×	97 0.4×	83	4.4k
T Naoe Japan	40	3.5k 1.2×	894 0.9×	3.0k 9.3×	186 0.7×	110 0.4×	207	6.4k
Luca Galli Italy	25	94 0.0×	80 0.1×	494 1.5×	704 2.6×	245 1.0×	140	2.1k
R. M. Hutchinson United Kingdom	15	594 0.2×	283 0.3×	240 0.7×	67 0.3×	59 0.2×	33	1.1k
J. Robert Cassady United States	24	251 0.1×	334 0.3×	216 0.7×	705 2.6×	483 1.9×	42	2.9k
Christopher J. François United States	38	222 0.1×	84 0.1×	241 0.7×	1.7k 6.5×	795 3.2×	193	4.6k
A Huber Switzerland	26	168 0.1×	66 0.1×	384 1.2×	383 1.4×	330 1.3×	154	2.6k

Countries citing papers authored by Keiji Nogami

Since Specialization

Citations

This map shows the geographic impact of Keiji Nogami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keiji Nogami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keiji Nogami more than expected).

Fields of papers citing papers by Keiji Nogami

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keiji Nogami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keiji Nogami. The network helps show where Keiji Nogami may publish in the future.

Co-authorship network of co-authors of Keiji Nogami

This figure shows the co-authorship network connecting the top 25 collaborators of Keiji Nogami. A scholar is included among the top collaborators of Keiji Nogami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keiji Nogami. Keiji Nogami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kashiwakura, Yuji, Yuto Nakajima, Tiago J. S. Lopes, et al.. (2025). Engineered coagulation factor VIII with enhanced secretion and coagulation potential for hemophilia A gene therapy. Blood. 147(4). 402–415.

Sakata, Asuka, Kohei Tatsumi, Naoki Matsumoto, et al.. (2025). Extravascular coagulation regulates haemostasis independently of activated platelet surfaces in an in vivo mouse model. Communications Biology. 8(1). 390–390.

Nakajima, Yuto, et al.. (2025). In vitro evaluation of global coagulation potential of emicizumab and warfarin using rotational thromboelastometry. International Journal of Hematology. 122(3). 381–391.

Ogiwara, Kenichi, et al.. (2025). Insights from in vitro global assays on possible doses of concomitant hemostatic agents in the presence of NXT007 in hemophilia A. Journal of Thrombosis and Haemostasis. 23(7). 2164–2177.

Nakajima, Yuto, et al.. (2024). The combination of Asp519Val/Glu665Val and Lys1813Ala mutations in FVIII markedly increases coagulation potential. Blood Advances. 8(15). 3929–3940. 1 indexed citations

Nakajima, Yuto, et al.. (2024). ROTEM could be useful for lupus anticoagulant hypoprothrombinemia syndrome. Pediatrics International. 66(1). e15773–e15773. 1 indexed citations

Asai, Yuji, Tomoya Ueda, Maiko Takeda, et al.. (2023). The First Case in Japan of Fulminant Myocarditis Due to Multisystem Inflammatory Syndrome in Children (MIS-C) That Required Mechanical Circulatory Support. International Heart Journal. 64(4). 783–788. 3 indexed citations

Nakajima, Yuto, et al.. (2023). Hybrid human‐porcine factor VIII proteins partially escape the inhibitory effects of anti‐factor VIII inhibitor alloantibodies having A2 or C2 domain specificity. Haemophilia. 30(1). 140–150. 2 indexed citations

Nakajima, Yuto, et al.. (2022). Factor VIII mutated with Lys1813Ala within the factor IXa-binding region enhances intrinsic coagulation potential. Blood Advances. 7(8). 1436–1445. 6 indexed citations

10.

Morita, Makiko, Yasuyuki Arai, Takashi Ishihara, et al.. (2022). Relative hypercoagulation induced by suppressed fibrinolysis after tisagenlecleucel infusion in malignant lymphoma. Blood Advances. 6(14). 4216–4223. 8 indexed citations

11.

Ishihara, Takashi, et al.. (2021). Coagulation and fibrinolysis balance in disseminated intravascular coagulation. Pediatrics International. 63(11). 1311–1318. 7 indexed citations

12.

Ishihara, Takashi, et al.. (2021). Successful unrelated cord blood transplantation for Diamond–Blackfan anemia. Pediatrics International. 63(3). 356–358. 1 indexed citations

13.

Ishihara, Takashi, Keiji Nogami, Satoshi Ochi, et al.. (2019). Disordered hemostasis associated with severely depressed fibrinolysis demonstrated using a simultaneous thrombin and plasmin generation assay during L‐asparaginase induction therapy in pediatric acute lymphoblastic leukemia. Pediatric Blood & Cancer. 67(1). e28016–e28016. 8 indexed citations

14.

Ishihara, Takashi, et al.. (2018). Fibrinolytic abnormality associated with progression of pediatric solid tumor. Pediatrics International. 60(6). 540–546. 8 indexed citations

15.

Yada, Koji, Keiji Nogami, Tomoko Matsumoto, Takehisa Kitazawa, & Midori Shima. (2017). Increasing of Ternary Complex Formation By Predominant Accumulation of Factor (F)X Accompanied By Increase of Fixa Contributes to Enhancement of Clotting Function By Apcc in Combination with Emicizumab. Blood. 130. 3658–3658. 1 indexed citations

16.

Yada, Koji, Keiji Nogami, Masahiro Takeyama, et al.. (2015). Mild hemophilia A patient with novel Pro1809Leu mutation develops an anti‐C2 antibody inhibiting allogeneic but not autologous factor VIII activity. Journal of Thrombosis and Haemostasis. 13(10). 1843–1853. 4 indexed citations

17.

Ogiwara, Kenichi, Keiji Nogami, Tomoko Matsumoto, & Midori Shima. (2014). Tissue factor pathway inhibitor in activated prothrombin complex concentrates (aPCC) moderates the effectiveness of therapy in some severe hemophilia A patients with inhibitor. International Journal of Hematology. 99(5). 577–587. 17 indexed citations

18.

Nakao, Keisuke, Katsumi Hayakawa, Yasushi Hayakawa, et al.. (2012). PULSE STRUCTURE MEASUREMENT OF NEAR-INFRARED FEL IN BURST-MODE OPERATION OF LEBRA LINAC. 472–474. 1 indexed citations

19.

Soeda, Tetsuhiro, et al.. (2011). Interactions between residues 2228–2240 within factor VIIIa C2 domain and factor IXa Gla domain contribute to propagation of clot formation. Thrombosis and Haemostasis. 106(11). 893–900. 5 indexed citations

20.

Hirabayashi, Jun‐ichi, et al.. (2010). The behaviour of fluorine, chlorine, and sulphur in the magma of Merapi Vulcano Central Java – Indonesia. 1(3). 183–198. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact